InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Sullivan Eddie Joe, Chief Executive Officer. Officer active across 1 company, notably SAB Biotherapeutics, Inc.. Aggregated, 3 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €12k. History available since 7 September 2022. The latest transaction was disclosed on 7 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
1,740 shares@ US$0.8812.1% of flowCommon StockSEC:0000950170-23-068922:0
Canonical exit: 6 Mar 2024 (T+90)
14,000 shares@ US$0.736887.9% of flowCommon StockSEC:0001209191-22-049168:0
Canonical exit: 6 Dec 2022 (T+90)
5,213,764 sharesCommon StockSEC:0001493152-21-026387:0
3 of 3 declarations
About Sullivan Eddie Joe
Eddie Joe Sullivan is the Chief Executive Officer at SAB Biotherapeutics, Inc. He leads the operations of the company, implementing strategies to drive growth and innovation. His experience in the biopharmaceutical sector allows him to navigate effectively in complex environments.
